HealthEquity, Inc. (NASDAQ:HQY) Receives $110.71 Average PT from Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have earned an average rating of “Moderate Buy” from the fourteen analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $110.71.

HQY has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. BTIG Research raised their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. JMP Securities raised their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Finally, Royal Bank of Canada upped their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $95.62 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 3.20. The company has a market capitalization of $8.29 billion, a PE ratio of 87.72, a price-to-earnings-growth ratio of 1.10 and a beta of 0.55. The stock has a fifty day moving average of $94.06 and a 200-day moving average of $84.26. HealthEquity has a one year low of $62.10 and a one year high of $105.82.

Insiders Place Their Bets

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the sale, the director now owns 4,823 shares in the company, valued at $387,093.98. This trade represents a 20.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,786 shares of company stock worth $4,140,387 over the last 90 days. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Holocene Advisors LP bought a new position in shares of HealthEquity in the 3rd quarter worth about $1,246,000. GSA Capital Partners LLP purchased a new stake in shares of HealthEquity in the 3rd quarter worth approximately $638,000. Vaughan Nelson Investment Management L.P. grew its stake in shares of HealthEquity by 36.7% in the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after buying an additional 226,563 shares during the last quarter. Natixis Advisors LLC boosted its holdings in HealthEquity by 29.8% in the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after acquiring an additional 48,009 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its holdings in shares of HealthEquity by 29.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company’s stock valued at $5,535,000 after acquiring an additional 14,573 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.